Neuronetics is trading 6.05% up in pre-market at $3.33; healthcare-sector momentum is the most likely explanation.

  • Healthcare is up 1.55% pre-market as investors respond to strong second-quarter earnings and guidance across the industry.
  • No clearly reported company-specific announcement was identified on August 20, 2026.
  • Recent earnings strength and an insider purchase may be supporting sentiment, but those catalysts were reported earlier.